Aug 19 (Reuters) - Moderna and Merck said on Wednesday that a personalized mRNA cancer vaccine reduced the risk of recurrence ...

The companies have not published the trial data but said in a news release that the experimental treatment extended the time ...

CHICAGO, Aug 19 (Reuters) - Merck and Moderna's success with a personalized cancer vaccine designed to keep melanoma at bay ...

Merck and Moderna say the experimental treatment extended the time before skin cancer returned in patients at high risk.

Drug company stocks soared following news that Moderna and Merck’s experimental mRNA-based cancer vaccine succeeded in a late ...

By Michael Erman and Julie Steenhuysen Aug 19 (Reuters) - Moderna and Merck said on Wednesday that a personalized mRNA cancer ...

Merck and Moderna say their new vaccine can block the return of one of the deadliest cancers. These personalized mRNA ...

A cancer vaccine developed by Merck and Moderna treating patients with melanoma showed positive and promising late-stage ...

For Wednesday, Aug. 19, WGN's Lourdes Duarte, filling in for Dina Bair, has the latest on new medical information.

A personalized vaccine developed by Moderna Inc. and Merck & Co. helped reduce the recurrence of melanoma in a large, ...

Combining a vaccine and immunotherapy approach could open new ways to treat cancer.

A late-stage trial that combined a messenger ribonucleic acid (mRNA) shot jointly developed by Moderna (MRNA +130.82%) and ...